NCT03462719 2026-03-12GLOWJanssen Research & Development, LLCPhase 3 Active not recruiting211 enrolled 23 charts
NCT04075292 2026-03-05Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic LeukemiaAstraZenecaPhase 3 Active not recruiting155 enrolled 16 charts